US Healthcare Journal
SEE OTHER BRANDS

Get your fresh news on healthcare and wellness in the United States

US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on April 25, 2025

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

Best SARMs for Bulking, Cutting, Fat Loss & Muscle Growth: Top Selective Androgen Receptor Modulators Reviewed for Lean Gains & Shredded Physique From CrazyBulk

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- In recent years, SARMs have become a go-to solution for fitness enthusiasts seeking enhanced performance, lean muscle growth, and effective fat loss—without the risks associated with anabolic steroids. As …

Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC

Juvent Launches Next Generation Bone Health Supplement HydroxyBMD3 at the National Bone Health & Osteoporosis Foundation (BHOF) Symposium in Washington, DC

OOLTEWAH, Tenn., April 25, 2025 (GLOBE NEWSWIRE) -- Juvent, an innovator in clinically validated bone and musculoskeletal health solutions, debuted its revolutionary new supplement system HydroxyBMD3 at the National Bone Health …

My Grief Angels Inc Launches Mother's Day "Bouquet of Support" for Grieving Moms

My Grief Angels Inc Launches Mother's Day "Bouquet of Support" for Grieving Moms

THE WOODLANDS, Texas, April 25, 2025 (GLOBE NEWSWIRE) -- As Mother's Day approaches, My Grief Angels Inc, a renowned 501(c)(3) public charity, is extending a compassionate hand to mothers grappling with the loss of a loved one. Recognized as "One of the …

Mental Health Nonprofit Queer LifeSpace to Host Annual Fundraising Gala "Pride Renaissance: Celebrating Community Resilience"

Mental Health Nonprofit Queer LifeSpace to Host Annual Fundraising Gala "Pride Renaissance: Celebrating Community Resilience"

SAN FRANCISCO, April 25, 2025 (GLOBE NEWSWIRE) -- In the midst of a worsening mental health crisis and rising anti-LGBTQIA+ attacks nationwide, nonprofit counseling agency Queer LifeSpace will host its largest-ever fundraiser on Friday, May 30th, rallying …

Bassett Medical Center Earns Prestigious Magnet Designation for Nursing Excellence

Bassett Medical Center Earns Prestigious Magnet Designation for Nursing Excellence

Cooperstown, New York, April 25, 2025 (GLOBE NEWSWIRE) -- Bassett Medical Center in Cooperstown, NY, has achieved Magnet® Recognition for Nursing Excellence, the highest national honor a hospital can attain for nurse satisfaction, patient outcomes, and …

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025

BEDFORD, Mass., April 25, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its first quarter 2025 financial results before the …

Nextech to Unveil Powerful Eyecare Innovations at ASCRS Annual Meeting

Nextech to Unveil Powerful Eyecare Innovations at ASCRS Annual Meeting

Tampa, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Nextech, a leading technology provider for specialty medical and wellness practices, today announced it will preview the latest enhancements to its 2025 Best in KLAS®-winning technology platform at the …

ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints

In ASPEN-03 and ASPEN-04 trials, efficacy data do not support advancing evorpacept in combination with Merck’s anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), into a registrational study Company remains confident in continuing to pursue evorpacept in …

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

Mangoceuticals Announces Strategic Entry into High Growth Pouch Industry Through Acquisition of Smokeless Technology IP and Appointment of Tim Corkum Ex Philip Morris Executive to Lead High Growth Pouch Division

DALLAS, TX, April 25, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals Inc. (NASDAQ: MGRX) (“Mangoceuticals” or “MGRX”), a company focused on developing, marketing, and selling a variety of health and wellness products via a secure telemedicine platform under the …

The Ebony Canal, Narrated by Viola Davis Wins Big with Two International Webby Awards for Black Infant and Maternal Health

The Ebony Canal, Narrated by Viola Davis Wins Big with Two International Webby Awards for Black Infant and Maternal Health

New York, New York, April 25, 2025 (GLOBE NEWSWIRE) -- Less than a week following National Black Maternal Health Week, The Ebony Canal, directed by four-time Emmy Award-winner Emmai Alaquiva and narrated by EGOT winner Viola Davis, has been honored with …

Better Choice Company Cancels Previously Announced Stock Dividend

Better Choice Company Cancels Previously Announced Stock Dividend

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced that it is canceling the previously declared stock dividend of 0.35 per …

Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price

Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price

TAMPA, Fla., April 25, 2025 (GLOBE NEWSWIRE) -- Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, today announced the closing of its business combination with SRx Health Solutions, Inc. …

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders

WALTHAM, Mass. and BOULDER, Colo., April 25, 2025 (GLOBE NEWSWIRE) -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced preclinical data from four …

Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Awards 2025

Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Awards 2025

Dr. Mohana Rao Patibandla Honored as India’s Best Minimally Invasive Neurosurgeon at Sardar Patel Unity Summit …

Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!

Flush Factor Plus Reviews (Complaints & Side Effects) Investigative Report on Its Effectiveness for Joint Health!

MIAMI, April 25, 2025 (GLOBE NEWSWIRE) -- Flush Factor Plus is a natural dietary supplement that claims to support fluid retention and promote joint mobility and flexibility. Knee pain and joint issues due to improper fluid circulation are common issues …

Best Over the Counter (OTC) Appetite Suppressant Pills 2025: Strongest Natural Hunger Control Suppressants from PhenQ

Best Over the Counter (OTC) Appetite Suppressant Pills 2025: Strongest Natural Hunger Control Suppressants from PhenQ

New York City, April 25, 2025 (GLOBE NEWSWIRE) -- Struggling with constant cravings or late-night snacking? You're not alone. In 2025, appetite control has become one of the most critical challenges in any successful weight loss journey. That’s why …

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

Y-mAbs Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating CD38-SADA Pre-targeted Radioimmunotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel radioimmunotherapy and antibody-based …

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BPGbio Highlights Groundbreaking Data on BPM31510 for Mitochondrial Diseases at the Inaugural Mitochondrial Transplantation and Next Generation Therapeutics Conference

BOSTON, April 25, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a leading biology-first, AI-powered clinical-stage biopharma company focused on mitochondrial biology and protein homeostasis, today announced a poster presentation at the inaugural Mitochondrial …

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

A Place to Heal: Virtue Recovery Center Stands with Veterans and Families Across the United States

LAS VEGAS, April 25, 2025 (GLOBE NEWSWIRE) -- When military service ends, many Veterans find themselves facing a new kind of battle — one marked by PTSD, addiction, and the struggle to reconnect with daily life. With an average of 17 Veterans lost to …

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

Elixir Medical Announces First Use of LithiX Hertz Contact (HC) Intravascular Lithotripsy System (IVL) in Asia Pacific at Cardiac Vascular Sentral Kuala Lumpur (CVSKL), Malaysia

First cases completed by Dr. Tamil Selvan Muthusamy, MD, and Dr. Rosli Mohd Ali, MD, and transmitted live at TCTAP Congress in Seoul, Korea. Novel IVL technology designed to deliver calcium fragmentation for treatment of moderate to severely calcified …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service